Sotagliflozin (SAR439954)
Sotagliflozin (SAR439954) is a pharmaceutical drug with 18 clinical trials. Historical success rate of 88.9%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
1
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
88.9%
16 of 18 finished
11.1%
2 ended early
0
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sotagliflozin Bioequivalence Study
Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects
Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise
A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril
A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions
Clinical Trials (18)
Sotagliflozin Bioequivalence Study
Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female Subjects
Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise
A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril
A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions
Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female Subjects
Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin
Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects
A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects
A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol
Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension
A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide
Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea
Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects
Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy
Efficacy and Safety of Sotagliflozin Versus Placebo in Participants With Type 2 Diabetes Mellitus on Background of Sulfonylurea Alone or With Metformin
Efficacy and Safety of Sotagliflozin Versus Glimepiride and Placebo in Participants With Type 2 Diabetes Mellitus That Are Taking Metformin Monotherapy
Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus on Background of Metformin
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18